Excessive Platelet Sterilization Potentially Dangerous
|
By LabMedica International staff writers Posted on 22 Jun 2014 |
Chemical processes used to sterilize blood products could lead to serious health issues in transfusion recipients, according to a new study.
Researchers at Linköping University (Sweden), Université Laval (Québec, Canada), and other institutions documented the effects of pathogen reduction (PR) systems on microRNA and mRNA levels in platelets stored in the blood bank, and assessed their impact on platelet activation and function. The researchers compared the two standard PR methods, gamma irradiation alone or irradiation in combination with chemical substances that inactivate pathogenic agents by cross-linking to their nucleic acids (DNA and RNA).
The researchers found that unlike platelets subjected to gamma irradiation or stored in additive solution, the ones that were treated by the two PR systems available on the market, Intercept and Mirasol, aggregated badly, which worsened wound healing. Intercept also eradicated the nucleic acids of the platelets, causing them to become overactive and reduced in volume. Gamma radiation, on the other hand, had no damaging effects on the blood platelets. PR neither affected platelet microRNA synthesis or function, nor induced cross-linking of microRNA-sized endogenous platelet RNA species. The study was published early online on April 21, 2014, in Platelets.
“The processes that are used target the genetic material of pathogenic organisms; they were developed more than 20 years ago, before we understood the importance of the genetic material contained in platelets,” said corresponding author Patrick Provost, MD, of Université Laval. “These treatments activate blood platelets, triggering the release of RNA. The platelets end up depleted of RNA, so once transfused, they're unable to do what they normally would.”
“The problem is also that the blood platelets have nucleic acids that are very important for their wound healing abilities and communication with other cells,” added lead author clinical biochemist Abdimajid Osman, PhD, a researcher in Linköping University. “If they are eradicated it can damage the blood cells and lead to more severe bleeding for the patient. Our recommendation to blood centers is not to use any of the substances, only irradiation treatment.”
The function of platelets goes far beyond their role in blood coagulation and wound healing. They contain up to a third of the human genome in the form of ribonucleic acid (RNA), allowing them to synthesize over 1,000 proteins essential to the normal functioning of the human body. In contrast to other donated blood products, blood platelets must be stored at room temperature as they do not tolerate the cold. This entails a risk that pathogens such as bacteria and viruses develop and follow the platelets into the patient’s blood system. The consequence can be blood poisoning, in the worst case leading to death.
Related Links:
Linköping University
Université Laval
Researchers at Linköping University (Sweden), Université Laval (Québec, Canada), and other institutions documented the effects of pathogen reduction (PR) systems on microRNA and mRNA levels in platelets stored in the blood bank, and assessed their impact on platelet activation and function. The researchers compared the two standard PR methods, gamma irradiation alone or irradiation in combination with chemical substances that inactivate pathogenic agents by cross-linking to their nucleic acids (DNA and RNA).
The researchers found that unlike platelets subjected to gamma irradiation or stored in additive solution, the ones that were treated by the two PR systems available on the market, Intercept and Mirasol, aggregated badly, which worsened wound healing. Intercept also eradicated the nucleic acids of the platelets, causing them to become overactive and reduced in volume. Gamma radiation, on the other hand, had no damaging effects on the blood platelets. PR neither affected platelet microRNA synthesis or function, nor induced cross-linking of microRNA-sized endogenous platelet RNA species. The study was published early online on April 21, 2014, in Platelets.
“The processes that are used target the genetic material of pathogenic organisms; they were developed more than 20 years ago, before we understood the importance of the genetic material contained in platelets,” said corresponding author Patrick Provost, MD, of Université Laval. “These treatments activate blood platelets, triggering the release of RNA. The platelets end up depleted of RNA, so once transfused, they're unable to do what they normally would.”
“The problem is also that the blood platelets have nucleic acids that are very important for their wound healing abilities and communication with other cells,” added lead author clinical biochemist Abdimajid Osman, PhD, a researcher in Linköping University. “If they are eradicated it can damage the blood cells and lead to more severe bleeding for the patient. Our recommendation to blood centers is not to use any of the substances, only irradiation treatment.”
The function of platelets goes far beyond their role in blood coagulation and wound healing. They contain up to a third of the human genome in the form of ribonucleic acid (RNA), allowing them to synthesize over 1,000 proteins essential to the normal functioning of the human body. In contrast to other donated blood products, blood platelets must be stored at room temperature as they do not tolerate the cold. This entails a risk that pathogens such as bacteria and viruses develop and follow the platelets into the patient’s blood system. The consequence can be blood poisoning, in the worst case leading to death.
Related Links:
Linköping University
Université Laval
Latest Hematology News
- New Automated Hemostasis Systems Become Available Across US Laboratories
- Updated Ferritin Thresholds Improve Detection of Iron Deficiency
- Variation in AML Residual Disease Testing Prompts Push for Standardization
- Hidden Molecular Mechanism Behind HIT Blood-Clotting Disorder Revealed
- Borderline Anemia May Carry Higher Risk Than Current Thresholds Suggest
- Biomarker-Guided Framework Aims to Guide Mantle Cell Lymphoma Therapy
- New Genetic Findings Reveal Cause of Bone Marrow Failure Syndrome
- Ultra-Portable Device Enables Finger-Prick Blood Testing at Home
- Age-Specific CBC Reference Intervals Support Pediatric Diagnosis in Vietnam
- Spectral Flow Cytometry Assay Enhances MRD Detection in Multiple Myeloma
- New Marker Helps Detect Aggressive Multiple Myeloma Earlier
- New Biomarkers Predict Resistance to Targeted Therapy in Rare Blood Cancer
- AI Decision Support System Guides Treatment Selection for Complex Blood Cancers
- Blood Test Helps Predict Short-Term Mortality After Severe Heart Attack
- Next-Generation Hematology Platform Streamlines High-Complexity Lab Workflows
- Blood Eosinophil Count May Predict Cancer Immunotherapy Response and Toxicity
Channels
Clinical Chemistry
view channel
Blood Test Patterns Improve Cancer Risk Assessment in Primary Care
Unexplained weight loss is a common but nonspecific presentation in primary care that can precede several types of cancer, making referral decisions difficult. Routine blood tests may produce borderline... Read more
Multi-Biomarker Blood Test Shows Promise for Early Pancreatic Cancer Detection
Pancreatic cancer has the lowest survival rates of any cancer, with only 14% of patients alive five years after diagnosis. The disease is typically discovered after it has spread, and an estimated 90%... Read more
Machine Learning Supports Targeted Screening for Elevated Lipoprotein(a)
Lipoprotein(a) is an independent, genetically determined risk factor for atherosclerotic cardiovascular disease, yet routine screening remains uncommon despite guideline recommendations, leaving many high-risk... Read more
Blood Biomarker May Help Monitor Early Response to Lecanemab in Alzheimer’s Disease
Alzheimer’s disease is a progressive neurodegenerative disorder marked by amyloid-beta and tau pathology and remains a leading cause of cognitive decline in older adults. Although lecanemab, an anti-amyloid... Read moreMolecular Diagnostics
view channel
Rapid CRISPR Test Identifies Nontuberculous Mycobacteria Species from Respiratory Samples
Chronic lung infections caused by nontuberculous mycobacteria (NTM) are increasingly recognized but frequently mistaken for tuberculosis, complicating diagnosis and care. These infections may affect as... Read more
FDA Clears Compact Molecular COVID Test for Decentralized Care Settings
Decentralized healthcare settings such as urgent care clinics have historically struggled to deploy high-performance molecular testing. Barriers include high upfront costs, fixed testing capacity, large... Read moreHematology
view channel
Updated Ferritin Thresholds Improve Detection of Iron Deficiency
Iron deficiency is one of the most common health conditions worldwide, yet its nonspecific symptoms can delay diagnosis for months. Variation in testing practices and ferritin thresholds may contribute... Read more
New Automated Hemostasis Systems Become Available Across US Laboratories
Hemostasis testing supports critical decisions in surgery, anticoagulation management, and the evaluation of bleeding and thrombotic disorders, but laboratories continue to face rising volumes and complex... Read moreImmunology
view channel
Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead
Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more
New Cellular Map May Help Predict Crohn’s Disease Course in Children
Crohn’s disease in children is a common and debilitating form of inflammatory bowel disease, marked by chronic intestinal inflammation and limited pediatric-specific treatments. Clinicians must decide... Read more
Temporal Immune Profiling Reveals How Sepsis States Change Over Time
Sepsis is a life-threatening condition in which the immune response to infection becomes dysregulated, leading to rapid organ failure and death. Although antimicrobials and organ support remain standard... Read more
Study Identifies Immune Cells That Drive Harmful Autoantibody Responses in COVID-19
Autoantibodies that mistakenly attack the body’s own tissues have been linked to severe COVID-19, Long COVID, and increased risk of autoimmune disease. However, the origins of these autoantibodies during... Read moreMicrobiology
view channelMagnetic Nanoparticles Enable More Sensitive Beta-Lactam Allergy Testing
Penicillin allergy labels are common in clinical practice, yet many are incorrect and can lead to suboptimal antibiotic choices. Although 8%–25% of people report a penicillin allergy, only 1%–10% are truly... Read more
Infant Skin Microbiome Show Links to Later Eczema and Food Allergies
Eczema, or atopic dermatitis, and food allergies often begin in infancy and are among the earliest stages of the atopic march. Atopic dermatitis alone can affect up to 20% of children, yet objective indicators... Read more
Diagnostic Stewardship Guide Targets Testing Overuse and Hospital Cost Pressures
Hospitals face persistent pressure to improve diagnostic accuracy while reducing unnecessary testing and costs. Misordered or overused assays can complicate infection metrics, trigger penalties, and strain... Read more
Research Strengthens Bundibugyo Virus Outbreak Readiness with Faster Diagnostics
Bundibugyo virus (BDBV), a species of ebolavirus, causes severe hemorrhagic disease and can be difficult to diagnose rapidly during outbreaks. Recent regulatory changes have further complicated swift deployment... Read morePathology
view channel
Machine Learning Cytology Tool Improves Cancer Cell Identification
Cytological screening remains central to early cancer detection, but its accuracy depends heavily on expert interpretation of stained cells. Under conventional microscopy, malignant and reactive cells... Read more
Tumor Budding Grading May Predict Chemotherapy Benefit in Resected Lung Squamous Cancer
Outcomes after resection for lung squamous cell carcinoma (SqCC) vary substantially, and the uneven benefit of adjuvant chemotherapy complicates postsurgical treatment decisions. Pathologic markers that... Read more
CAP Updates Cancer Protocols to Refine Breast Cancer Biomarker Reporting and GIST Molecular Testing
Standardized biomarker reporting and molecular profiling are central to pathology-driven cancer care, but evolving practices require laboratories to keep reporting templates current. These templates capture... Read moreTechnology
view channel
ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine
Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more
Multimodal AI Framework Aims to Guide Cancer Immunotherapy Decisions
Cancer immunotherapy has reshaped oncology, but heterogeneous responses and immune-related toxicities continue to complicate routine decision-making. Standard biomarkers, including programmed death-ligand... Read more
New Multipurpose Centrifuge Combines High Capacity with Sustainable Cooling
Laboratories often need centrifugation that accommodates multiple vessel formats while maintaining controlled temperatures to protect sensitive samples. Intuitive controls and repeatable operation can... Read more
Bacterial Vesicle Expression System Streamlines Production of Cancer Diagnostic Proteins
Recombinant proteins are central to many cancer diagnostics and therapies, but numerous targets remain difficult and costly to produce because they are unstable, toxic to microbial hosts, or require precise folding.... Read moreIndustry
view channel
Veracyte Acquisition Expands Urine-Based Bladder Cancer Monitoring Capabilities
Veracyte, Inc. has acquired Convergent Genomics, expanding its urology diagnostics offerings with the company’s UroAmp platform and proprietary urinary tumor DNA (utDNA) technology. UroAmp has been clinically... Read more
Unilabs Expands Digital Pathology Across European Network with Proscia Platform
As precision medicine expands, digital pathology platforms must connect teams, sites, diagnostic data, and artificial intelligence to accelerate routine diagnosis. Sharing expertise across laboratory networks... Read more
MGI Launches Automated Multiplex Tissue Staining and Imaging System at ECP 2026
MGI Tech Co., Ltd. (Shenzhen, China) introduced VisiOmics (PMIF-20RS), a fully automated multiplex immunofluorescence staining and imaging system, at the 38th European Congress of Pathology (ECP 2026)... Read more







